- Home
- KZIA vs RVYL Comparison
KZIA vs RVYL Comparison
Compare KZIA & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- RVYL
- Stock Information
- Founded
- KZIA 1994
- RVYL 2007
- Country
- KZIA Australia
- RVYL United States
- Employees
- KZIA N/A
- RVYL N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- RVYL Professional Services
- Sector
- KZIA Health Care
- RVYL Consumer Discretionary
- Exchange
- KZIA Nasdaq
- RVYL Nasdaq
- Market Cap
- KZIA 12.6M
- RVYL 13.3M
- IPO Year
- KZIA 1999
- RVYL N/A
- Fundamental
- Price
- KZIA $4.90
- RVYL $1.18
- Analyst Decision
- KZIA Strong Buy
- RVYL Hold
- Analyst Count
- KZIA 1
- RVYL 1
- Target Price
- KZIA $20.00
- RVYL N/A
- AVG Volume (30 Days)
- KZIA 148.4K
- RVYL 82.1K
- Earning Date
- KZIA 11-19-2024
- RVYL 11-14-2024
- Dividend Yield
- KZIA N/A
- RVYL N/A
- EPS Growth
- KZIA N/A
- RVYL N/A
- EPS
- KZIA N/A
- RVYL N/A
- Revenue
- KZIA $382.00
- RVYL $68,403,000.00
- Revenue This Year
- KZIA $4,053,954.00
- RVYL N/A
- Revenue Next Year
- KZIA N/A
- RVYL $52.56
- P/E Ratio
- KZIA N/A
- RVYL N/A
- Revenue Growth
- KZIA N/A
- RVYL 42.88
- 52 Week Low
- KZIA $1.90
- RVYL $0.89
- 52 Week High
- KZIA $15.80
- RVYL $5.48
- Technical
- Relative Strength Index (RSI)
- KZIA 50.25
- RVYL 35.73
- Support Level
- KZIA $5.21
- RVYL $1.46
- Resistance Level
- KZIA $6.88
- RVYL $2.01
- Average True Range (ATR)
- KZIA 0.76
- RVYL 0.20
- MACD
- KZIA -0.11
- RVYL -0.04
- Stochastic Oscillator
- KZIA 22.80
- RVYL 0.00
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.